That might be an interesting place to start, discussing the competitive dynamics on the imaging side. It's interesting to hear that Sectra and Visage are disrupting the market and taking share. There's also a narrative, often pushed by Visage, that their software is superior and they win all the head-to-heads with Sectra. I'm interested if you could provide any insights on those comments.

I normally like to remind myself of the history, so let's go over Sectra's competition narrative. Sectra has been a pioneer since the 1990s. Philips was a major distributor for Sectra on the license side until 2005, before they bought a competitor in the US, thinking Sectra would go bankrupt. However, Sectra ended up taking two-thirds of all the end customers in the US and other places, which fueled significant growth from 2005 onward.

That might be an interesting place to start, discussing the competitive dynamics on the imaging side. It's interesting to hear that Sectra and Visage are disrupting the market and taking share. There's also a narrative, often pushed by Visage, that their software is superior and they win all the head-to-heads with Sectra. I'm interested if you could provide any insights on those comments.

The transition to a RIS software, a radar information system, similar to an ERP for invoicing, also contributed to this growth. Today, it's essentially one system. The competition evolved from there, and Sectra became even stronger. In 2011, we sold the modality business in mammography to focus solely on software, moving away from hardware. From a financial and investment perspective, the transition to the cloud began around 2011. By 2015 or 2016, the push towards the cloud was very strong.

Why is that?

Culturally, and because Sectra has won that class for more than 10 years in a row. The big hospitals and production hospitals have that background. They have Kaiser Permanente and Stanford as references, which Visage doesn't have.